Authors:
DOWELL RI
SPRINGER CJ
DAVIES DH
HADLEY EM
BURKE PJ
BOYLE FT
MELTON RG
CONNORS TA
BLAKEY DC
MAUGER AB
Citation: Ri. Dowell et al., NEW MUSTARD PRODRUGS FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY - ALTERNATIVES TO THE AMIDE LINK, Journal of medicinal chemistry, 39(5), 1996, pp. 1100-1105
Authors:
BLAKEY DC
BURKE PJ
DAVIES DH
DOWELL RI
EAST SJ
ECKERSLEY KP
FITTON JE
MCDAID J
MELTON RG
NICULESCUDUVAZ IA
PINDER PE
SHARMA SK
WRIGHT AF
SPRINGER CJ
Citation: Dc. Blakey et al., ZD2767, AN IMPROVED SYSTEM FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY THAT RESULTS IN TUMOR REGRESSIONS IN COLORECTAL TUMOR XENOGRAFTS, Cancer research, 56(14), 1996, pp. 3287-3292
Authors:
ENOAMOOQUAYE EA
SEARLE F
BODEN JA
SHARMA SK
BURKE PJ
Citation: Ea. Enoamooquaye et al., ALTERED BIODISTRIBUTION OF AN ANTIBODY-ENZYME CONJUGATE MODIFIED WITHPOLYETHYLENE-GLYCOL, British Journal of Cancer, 73(11), 1996, pp. 1323-1327
Authors:
GORE SD
MILLER CB
WENG LJ
BURKS K
GRIFFIN CA
CHEN TL
BURKE PJ
GREVER M
ROWINSKY EK
Citation: Sd. Gore et al., IMPROVED HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) FOLLOWING ADMINISTRATION OF THE PUTATIVE DIFFERENTIATING AGENT SODIUM PHENYLBURYRATE (SPB), Blood, 88(10), 1996, pp. 2315-2315
Authors:
BURKE PJ
SCHOELKOPF RJ
PROBER DE
SKALARE A
MCGRATH WR
BUMBLE B
LEDUC HG
Citation: Pj. Burke et al., LENGTH SCALING OF BANDWIDTH AND NOISE IN HOT-ELECTRON SUPERCONDUCTINGMIXERS, Applied physics letters, 68(23), 1996, pp. 3344-3346
Authors:
SKALARE A
MCGRATH WR
BUMBLE B
LEDUC HG
BURKE PJ
VERHEIJEN AA
SCHOELKOPF RJ
PROBER DE
Citation: A. Skalare et al., LARGE BANDWIDTH AND LOW-NOISE IN A DIFFUSION-COOLED HOT-ELECTRON BOLOMETER MIXER, Applied physics letters, 68(11), 1996, pp. 1558-1560
Authors:
GORE SD
WENG LJ
JONES RJ
COWAN K
ZILCHA M
PIANTADOSI S
BURKE PJ
Citation: Sd. Gore et al., IMPACT OF IN-VIVO ADMINISTRATION OF INTERLEUKIN-3 ON PROLIFERATION, DIFFERENTIATION, AND CHEMOSENSITIVITY OF ACUTE MYELOID-LEUKEMIA, Clinical cancer research, 1(3), 1995, pp. 295-303
Authors:
SKALARE A
MCGRATH WR
BUMBLE B
LEDUC HG
BURKE PJ
VERHEIJEN AA
PROBER DE
Citation: A. Skalare et al., A HETERODYNE RECEIVER AT 533 GHZ USING A DIFFUSION-COOLED SUPERCONDUCTING HOT-ELECTRON BOLOMETER MIXER, IEEE transactions on applied superconductivity, 5(2), 1995, pp. 2236-2239
Authors:
BLAKEY DC
BURKE PJ
DAVIES DH
DOWELL RI
MELTON RG
SPRINGER CJ
WRIGHT AF
Citation: Dc. Blakey et al., ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) FOR TREATMENT OF MAJOR SOLID TUMOR DISEASE, Biochemical Society transactions, 23(4), 1995, pp. 1047-1050
Authors:
SPRINGER CJ
DOWELL R
BURKE PJ
HADLEY E
DAVIES DH
BLAKEY DC
MELTON RG
NICULESCUDUVAZ I
Citation: Cj. Springer et al., OPTIMIZATION OF ALKYLATING AGENT PRODRUGS DERIVED FROM PHENOL AND ANILINE MUSTARDS - A NEW CLINICAL CANDIDATE PRODRUG (ZD2767) FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT), Journal of medicinal chemistry, 38(26), 1995, pp. 5051-5065
Citation: Sh. Kaufmann et al., CHANGES IN TOPOISOMERASE-I LEVELS AND LOCALIZATION DURING MYELOID MATURATION IN-VITRO AND IN-VIVO, Cancer research, 55(6), 1995, pp. 1255-1260
Authors:
ROGERS GT
BURKE PJ
SHARMA SK
KOODIE R
BODEN JA
Citation: Gt. Rogers et al., PLASMA-CLEARANCE OF AN ANTIBODY-ENZYME CONJUGATE IN ADEPT BY MONOCLONAL ANTI-ENZYME - ITS EFFECT ON PRODRUG ACTIVATION IN-VIVO, British Journal of Cancer, 72(6), 1995, pp. 1357-1363
Authors:
BLAKEY DC
DAVIES DH
DOWELL RI
EAST SJ
BURKE PJ
SHARMA SK
SPRINGER CJ
MAUGER AB
MELTON RG
Citation: Dc. Blakey et al., ANTITUMOR EFFECTS OF AN ANTIBODY-CARBOXYPEPTIDASE G2 CONJUGATE IN COMBINATION WITH PHENOL MUSTARD PRODRUGS, British Journal of Cancer, 72(5), 1995, pp. 1083-1088
Citation: Sd. Gore et Pj. Burke, LONG-TERM SURVIVAL OF SUBSETS OF PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH INTENSIVE CHEMOTHERAPY, Blood, 86(10), 1995, pp. 1342-1342
Authors:
BURKE PJ
ZAHURAK M
GORE SD
ADJEI A
STRYZAK J
Citation: Pj. Burke et al., THE PROGNOSTIC FACTOR SCORE MODEL AND A SEQUENTIAL LIKELIHOOD RATIO TEST RAPIDLY DETERMINE THE VALUE OF TRANSLATIONAL INTERVENTION IN PATIENTS WITH MINIMAL RESIDUAL AML, Blood, 86(10), 1995, pp. 2995-2995
Authors:
SCHNEIDER E
COWAN KH
BADER H
TOOMEY S
SCHWARTZ GN
KARP JE
BURKE PJ
KAUFMANN SH
Citation: E. Schneider et al., INCREASED EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE IN RELAPSED ACUTE-LEUKEMIA, Blood, 85(1), 1995, pp. 186-193
Authors:
GORE SD
DONNENBERG AD
ZEHNBAUER BA
WENG LJ
BURKE PJ
Citation: Sd. Gore et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (CM-CSF), GIVEN CONCURRENTLY WITH INDUCTION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML), AUGMENTS THE SYNDROME OF T-LYMPHOCYTE RECOVERY, Leukemia, 8(3), 1994, pp. 409-419
Citation: Sd. Gore et al., IDENTIFICATION OF GROWTH FACTOR-RESPONSIVE ACUTE MYELOGENOUS LEUKEMIABASED ON FACTOR-DEPENDENCE FOR SURVIVAL AND PROLIFERATION, Leukemia, 8(11), 1994, pp. 1854-1863
Authors:
ROWINSKY EK
ADJEI A
DONEHOWER RC
GORE SD
JONES RJ
BURKE PJ
CHENG YC
GROCHOW LB
KAUFMANN SH
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACODYNAMIC STUDY OF THE TOPOISOMERASE I-INHIBITOR TOPOTECAN IN PATIENTS WITH REFRACTORY ACUTE-LEUKEMIA, Journal of clinical oncology, 12(10), 1994, pp. 2193-2203
Citation: Lj. Weng et al., WILL GROWTH-FACTOR AUGMENTATION DURING POSTREMISSION THERAPY FOR AML OVERCOME DRUG-RESISTANCE, Experimental hematology, 22(8), 1994, pp. 772-772
Citation: At. Church et Pj. Burke, EXPLORATORY AND CONFIRMATORY TESTS OF THE BIG 5 AND TELLEGENS 3- AND 4-DIMENSIONAL MODELS, Journal of personality and social psychology, 66(1), 1994, pp. 93-114
Authors:
MAUGER AB
BURKE PJ
SOMANI HH
FRIEDLOS F
KNOX RJ
Citation: Ab. Mauger et al., SELF-IMMOLATIVE PRODRUGS - CANDIDATES FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY IN CONJUNCTION WITH A NITROREDUCTASE ENZYME, Journal of medicinal chemistry, 37(21), 1994, pp. 3452-3458